SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000154
Filing Date
2022-11-07
Accepted
2022-11-07 08:00:30
Documents
10
Period of Report
2022-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesnform3q2022earningsrele.htm 8-K 27198
2 EX-99.1 ex991_3q2022earningsrele.htm EX-99.1 31716
3 ex991_3q2022earningsrele001.jpg GRAPHIC 239851
4 ex991_3q2022earningsrele002.jpg GRAPHIC 284016
5 ex991_3q2022earningsrele003.jpg GRAPHIC 308628
6 ex991_3q2022earningsrele004.jpg GRAPHIC 335579
7 ex991_3q2022earningsrele005.jpg GRAPHIC 337503
8 ex991_3q2022earningsrele006.jpg GRAPHIC 224405
9 ex991_3q2022earningsrele007.jpg GRAPHIC 150442
10 ex991_3q2022earningsrele008.jpg GRAPHIC 143904
  Complete submission text file 0001485003-22-000154.txt   2849074
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221363775
SIC: 2834 Pharmaceutical Preparations